 |
|
|
| |
ART Reduces T Cell Activation and Immune Exhaustion Markers in HIV Controllers
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Jonathan Li1, Florencia Segal1, Ronald Bosch2, Christina Lalama2, Randall Tressler3, Cornelius Van Dam4, Michael Keefer5, Mary Carrington6, Mathias Lichterfeld1, Daniel Kuritzkes1, Xu Yu7, Alan Landay8, Paul Sax1, and the AIDS Clinical Trials Group A5308 Study Team
1 Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 2Harvard T.H. Chan School of Public Health, Boston, MA, 3National Institutes of Health, Bethesda, MD, 4University of North Carolina, Greensboro, NC, 5University of Rochester School of Medicine and Dentistry, Rochester, NY, 6NCI-Frederick, Frederick, MD, 7Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 8Rush University Medical Center, Chicago, IL
|
| |
|
|
|
|
|
